Michele Marino

Via Paradisa 2
Pisa, 56124, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 107 publications

Serum mTOR: an associative marker of Graves' orbitopathy.

Serum mTOR: an associative marker of Graves' orbitopathy.

Journal: Journal of endocrinological investigation

Published: February 03, 2026

Markers of fibrosis in orbital tissues from patients graves' orbitopathy: a retrospective cohort study.

Markers of fibrosis in orbital tissues from patients graves' orbitopathy: a retrospective cohort study.

Journal: Journal of endocrinological investigation

Published: November 19, 2025

Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy.

Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy.

Journal: European thyroid journal

Published: October 16, 2025

Letter: Prolonged Treatment with Sirolimus (Rapamycin) for Graves' Orbitopathy.

Letter: Prolonged Treatment with Sirolimus (Rapamycin) for Graves' Orbitopathy.

Journal: Thyroid : official journal of the American Thyroid Association

Published: July 29, 2025

Sirolimus for the treatment of Graves' orbitopathy.

Sirolimus for the treatment of Graves' orbitopathy.

Journal: Thyroid research

Published: May 08, 2025

Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort Study.

Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: February 05, 2025

In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathy.

In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathy.

Journal: Endocrine

Published: January 14, 2025

Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimus.

Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimus.

Journal: Journal of endocrinological investigation

Published: January 14, 2025

Graves disease: latest understanding of pathogenesis and treatment options.

Graves disease: latest understanding of pathogenesis and treatment options.

Journal: Nature reviews. Endocrinology

Published: June 20, 2024

Long-term outcome of Graves' orbitopathy following treatment with sirolimus.

Long-term outcome of Graves' orbitopathy following treatment with sirolimus.

Journal: Journal of endocrinological investigation

Published: June 07, 2024

Role of genetics and epigenetics in Graves' orbitopathy.

Role of genetics and epigenetics in Graves' orbitopathy.

Journal: European thyroid journal

Published: June 04, 2024

Ocular surface disease index in Graves' orbitopathy: a cross-sectional study.

Ocular surface disease index in Graves' orbitopathy: a cross-sectional study.

Journal: Frontiers in endocrinology

Published: May 05, 2024

Showing 1-12 of 107

Last Updated: 09/26/2026